204 related articles for article (PubMed ID: 25245764)
1. Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function.
Pan J; Zhang Q; Liu Q; Komas SM; Kalyanaraman B; Lubet RA; Wang Y; You M
Cancer Prev Res (Phila); 2014 Nov; 7(11):1149-59. PubMed ID: 25245764
[TBL] [Abstract][Full Text] [Related]
2. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells.
Chilampalli C; Guillermo R; Kaushik RS; Young A; Chandrasekher G; Fahmy H; Dwivedi C
Exp Biol Med (Maywood); 2011 Nov; 236(11):1351-9. PubMed ID: 21908486
[TBL] [Abstract][Full Text] [Related]
3. Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2-FGFR1 autocrine loop.
Cen M; Yao Y; Cui L; Yang G; Lu G; Fang L; Bao Z; Zhou J
Cancer Med; 2018 Dec; 7(12):6205-6218. PubMed ID: 30515999
[TBL] [Abstract][Full Text] [Related]
4. Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.
Singh T; Gupta NA; Xu S; Prasad R; Velu SE; Katiyar SK
Oncotarget; 2015 Aug; 6(25):21268-82. PubMed ID: 26020804
[TBL] [Abstract][Full Text] [Related]
5. Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
Song JM; Anandharaj A; Upadhyaya P; Kirtane AR; Kim JH; Hong KH; Panyam J; Kassie F
Oncotarget; 2016 Sep; 7(36):57752-57769. PubMed ID: 27458163
[TBL] [Abstract][Full Text] [Related]
6. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
7. Histopathological effect of pterostilbene as chemoprevention in N-nitroso-tri-chloroethylurea (NTCU)-induced lung squamous cell carcinoma (SCC) mouse model.
Surien O; Ghazali AR; Masre SF
Histol Histopathol; 2020 Oct; 35(10):1159-1170. PubMed ID: 32893871
[TBL] [Abstract][Full Text] [Related]
8. Tracheal dysplasia precedes bronchial dysplasia in mouse model of N-nitroso trischloroethylurea induced squamous cell lung cancer.
Ghosh M; Dwyer-Nield LD; Kwon JB; Barthel L; Janssen WJ; Merrick DT; Keith RL
PLoS One; 2015; 10(4):e0122823. PubMed ID: 25860262
[TBL] [Abstract][Full Text] [Related]
9. Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model.
Jiang QQ; Fan LY; Yang GL; Guo WH; Hou WL; Chen LJ; Wei YQ
BMC Cancer; 2008 Aug; 8():242. PubMed ID: 18706101
[TBL] [Abstract][Full Text] [Related]
10. Honokiol Is a Potential Therapeutic Agent and Has a Synergistic Effect With 5-FU in Human Urothelial Cell Carcinoma Cells.
Lee MY; Shi CS; Hsu YC; Huang KJ; Chen SH; Zhao PW; Chung HC; Huang YC; Lee YR
Anticancer Res; 2019 Dec; 39(12):6555-6565. PubMed ID: 31810921
[TBL] [Abstract][Full Text] [Related]
11. Chemopreventive effects of honokiol on UVB-induced skin cancer development.
Chilampalli S; Zhang X; Fahmy H; Kaushik RS; Zeman D; Hildreth MB; Dwivedi C
Anticancer Res; 2010 Mar; 30(3):777-83. PubMed ID: 20392996
[TBL] [Abstract][Full Text] [Related]
12. Formylated honokiol analogs showed antitumor activity against lung carcinoma.
Deng S; Zhang C; Yang L; Ma L
Anticancer Drugs; 2019 Sep; 30(8):795-802. PubMed ID: 30807551
[TBL] [Abstract][Full Text] [Related]
13. Synergistic killing effect of paclitaxel and honokiol in non-small cell lung cancer cells through paraptosis induction.
Li XQ; Ren J; Wang Y; Su JY; Zhu YM; Chen CG; Long WG; Jiang Q; Li J
Cell Oncol (Dordr); 2021 Feb; 44(1):135-150. PubMed ID: 32936421
[TBL] [Abstract][Full Text] [Related]
14. Honokiol induces reactive oxygen species-mediated apoptosis in Candida albicans through mitochondrial dysfunction.
Sun L; Liao K; Hang C; Wang D
PLoS One; 2017; 12(2):e0172228. PubMed ID: 28192489
[TBL] [Abstract][Full Text] [Related]
15. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
Leeman-Neill RJ; Cai Q; Joyce SC; Thomas SM; Bhola NE; Neill DB; Arbiser JL; Grandis JR
Clin Cancer Res; 2010 May; 16(9):2571-9. PubMed ID: 20388852
[TBL] [Abstract][Full Text] [Related]
16. Honokiol induces apoptosis and autophagy via the ROS/ERK1/2 signaling pathway in human osteosarcoma cells in vitro and in vivo.
Huang K; Chen Y; Zhang R; Wu Y; Ma Y; Fang X; Shen S
Cell Death Dis; 2018 Feb; 9(2):157. PubMed ID: 29410403
[TBL] [Abstract][Full Text] [Related]
17. Discovery and synthesis of novel magnolol derivatives with potent anticancer activity in non-small cell lung cancer.
Tang H; Zhang Y; Li D; Fu S; Tang M; Wan L; Chen K; Liu Z; Xue L; Peng A; Ye H; Chen L
Eur J Med Chem; 2018 Aug; 156():190-205. PubMed ID: 30006164
[TBL] [Abstract][Full Text] [Related]
18. Honokiol attenuate the arsenic trioxide-induced cardiotoxicity by reducing the myocardial apoptosis.
Huang AL; Yang F; Cheng P; Liao DY; Zhou L; Ji XL; Peng DD; Zhang L; Cheng TT; Ma L; Xia XG
Pharmacol Res Perspect; 2022 Apr; 10(2):e00914. PubMed ID: 35171536
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo.
Singh T; Prasad R; Katiyar SK
Epigenetics; 2013 Jan; 8(1):54-65. PubMed ID: 23221619
[TBL] [Abstract][Full Text] [Related]
20. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
